BRAINSTORM CELL THERAPEUTICS INC. Basic Shares Outstanding (Weighted Average)
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) reported Basic Shares Outstanding (Weighted Average) of 11.03 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- BRAINSTORM CELL THERAPEUTICS INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 11.03M shares, a 28.01% increase year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 11.03M shares, a 74.00% increase year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 11.05M shares, a 93.66% increase year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 11.01M shares, a 107.32% increase year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. weighted average number of shares outstanding, basic for fiscal 2025 was 9.27M shares, a 84.57% increase from fiscal 2024.
- BRAINSTORM CELL THERAPEUTICS INC. weighted average number of shares outstanding, basic for fiscal 2024 was 5.02M shares, a 74.87% increase from fiscal 2023.
- BRAINSTORM CELL THERAPEUTICS INC. weighted average number of shares outstanding, basic for fiscal 2023 was 2.87M shares, a 92.13% decline from fiscal 2022.
- BRAINSTORM CELL THERAPEUTICS INC. weighted average number of shares outstanding, basic for fiscal 2022 was 36.51M shares, a 0.90% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 11.03M shares 10-Q · filed 2026-08-14 | 11.03M shares 10-Q · filed 2026-08-14 | 11.04M shares derived: average of 3 quarters · filed 2026-08-14 | 11.03M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | 11.03M shares 10-Q · filed 2026-05-15 | 11.04M shares derived: average of 2 quarters · filed 2026-05-15 | 11.03M shares derived: average of 3 quarters · filed 2026-05-15 | 10.43M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | 11.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 11.03M shares derived: average of 2 quarters · filed 2026-03-31 | 10.23M shares derived: average of 3 quarters · filed 2026-08-14 | 9.27M shares 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | 11.01M shares 10-Q · filed 2025-11-14 | 9.81M shares derived: average of 2 quarters · filed 2026-08-14 | 8.67M shares 10-Q · filed 2025-11-14 | 7.92M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | 8.62M shares 10-Q · filed 2026-08-14 | 7.49M shares 10-Q · filed 2026-08-14 | 6.89M shares derived: average of 3 quarters · filed 2026-08-14 | 6.50M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | 6.34M shares 10-Q · filed 2026-05-15 | 6.03M shares derived: average of 2 quarters · filed 2026-05-15 | 5.79M shares derived: average of 3 quarters · filed 2026-05-15 | 5.53M shares derived: average of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | 5.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 5.51M shares derived: average of 2 quarters · filed 2026-03-31 | 5.26M shares derived: average of 3 quarters · filed 2026-03-31 | 5.02M shares 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | 5.31M shares 10-Q · filed 2025-11-14 | 5.03M shares derived: average of 2 quarters · filed 2025-11-14 | 4.79M shares 10-Q · filed 2025-11-14 | 4.45M shares derived: average of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | 4.75M shares 10-Q · filed 2025-08-14 | 71.22M shares 10-Q · filed 2024-08-14 | 4.53M shares 10-Q · filed 2025-08-14 | 67.98M shares 10-Q · filed 2024-08-14 | 4.17M shares derived: average of 3 quarters · filed 2025-08-14 | 3.86M shares derived: average of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | 4.32M shares 10-Q · filed 2025-05-15 | 64.74M shares 10-Q · filed 2024-05-14 | 3.88M shares derived: average of 2 quarters · filed 2025-05-15 | 3.57M shares derived: average of 3 quarters · filed 2025-05-15 | 12.60M shares derived: average of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | 3.44M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 3.19M shares derived: average of 2 quarters · filed 2025-03-31 | 15.36M shares derived: average of 3 quarters · filed 2025-03-31 | 2.87M shares 10-K · filed 2025-03-31 | 43.08M shares 10-K · filed 2024-04-01 | |||
| 2023-09-30 | 2.95M shares 10-Q · filed 2024-11-14 | 44.25M shares 10-Q · filed 2023-11-14 | 21.32M shares derived: average of 2 quarters · filed 2024-11-14 | 2.68M shares 10-Q · filed 2024-11-14 | 40.26M shares 10-Q · filed 2023-11-14 | 29.00M shares derived: average of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | 39.70M shares 10-Q · filed 2024-08-14 | 38.22M shares 10-Q · filed 2024-08-14 | 37.68M shares derived: average of 3 quarters · filed 2024-08-14 | 37.39M shares derived: average of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | 36.74M shares 10-Q · filed 2024-05-14 | 36.68M shares derived: average of 2 quarters · filed 2024-05-14 | 36.62M shares derived: average of 3 quarters · filed 2024-05-14 | 36.58M shares derived: average of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | 36.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 36.56M shares derived: average of 2 quarters · filed 2024-04-01 | 36.53M shares derived: average of 3 quarters · filed 2024-04-01 | 36.51M shares 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | 36.49M shares 10-Q · filed 2023-11-14 | 36.49M shares derived: average of 2 quarters · filed 2023-11-14 | 36.47M shares 10-Q · filed 2023-11-14 | 36.43M shares derived: average of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | 36.49M shares 10-Q · filed 2023-08-14 | 36.46M shares 10-Q · filed 2023-08-14 | 36.41M shares derived: average of 3 quarters · filed 2023-08-14 | 36.38M shares derived: average of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | 36.44M shares 10-Q · filed 2023-05-15 | 36.37M shares derived: average of 2 quarters · filed 2023-05-15 | 36.35M shares derived: average of 3 quarters · filed 2023-05-15 | 36.34M shares derived: average of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | 36.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 36.31M shares derived: average of 2 quarters · filed 2023-03-30 | 36.31M shares derived: average of 3 quarters · filed 2023-03-30 | 36.18M shares 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | 36.30M shares 10-Q · filed 2022-11-14 | 36.31M shares derived: average of 2 quarters · filed 2022-11-14 | 36.14M shares 10-Q · filed 2022-11-14 | 35.43M shares derived: average of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | 36.32M shares 10-Q · filed 2022-08-15 | 36.06M shares 10-Q · filed 2022-08-15 | 35.14M shares derived: average of 3 quarters · filed 2022-08-15 | 34.14M shares derived: average of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | 35.79M shares 10-Q · filed 2022-05-16 | 34.55M shares derived: average of 2 quarters · filed 2022-05-16 | 33.42M shares derived: average of 3 quarters · filed 2022-05-16 | |||||
| 2020-12-31 | 33.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | 32.23M shares derived: average of 2 quarters · filed 2022-03-28 | 29.85M shares 10-K · filed 2022-03-28 | |||||
| 2020-09-30 | 31.15M shares 10-Q · filed 2021-11-15 | 28.70M shares 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |